These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22536837

  • 21. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
    McNicholas TA, Dean JD, Mulder H, Carnegie C, Jones NA.
    BJU Int; 2003 Jan; 91(1):69-74. PubMed ID: 12614254
    [Abstract] [Full Text] [Related]

  • 22. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL, Morgentaler A.
    Int J Impot Res; 2006 Jan; 18(2):201-5. PubMed ID: 16177827
    [Abstract] [Full Text] [Related]

  • 23. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ, Wang C, Fortigel Study Group.
    J Androl; 2010 Jan; 31(3):281-7. PubMed ID: 19959827
    [Abstract] [Full Text] [Related]

  • 24. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men.
    Bloch M, Rubinow DR, Berlin K, Kevala KR, Kim HY, Schmidt PJ.
    Arch Gen Psychiatry; 2006 Apr; 63(4):450-6. PubMed ID: 16585475
    [Abstract] [Full Text] [Related]

  • 25. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 26. Effects of testosterone replacement in hypogonadal men.
    Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2670-7. PubMed ID: 10946864
    [Abstract] [Full Text] [Related]

  • 27. The effects of pharmacologically induced hypogonadism on mood in healthy men.
    Schmidt PJ, Berlin KL, Danaceau MA, Neeren A, Haq NA, Roca CA, Rubinow DR.
    Arch Gen Psychiatry; 2004 Oct; 61(10):997-1004. PubMed ID: 15466673
    [Abstract] [Full Text] [Related]

  • 28. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C, Bellini M, Berra M, Meriggiola MC, Aloisi AM.
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [Abstract] [Full Text] [Related]

  • 29. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost.
    Taylor F, Levine L.
    J Sex Med; 2010 Jan; 7(1 Pt 1):269-76. PubMed ID: 19694928
    [Abstract] [Full Text] [Related]

  • 30. Absorption of testosterone gel 1% (Testim) from three different application sites.
    Guay AT, Smith TM, Offutt LA.
    J Sex Med; 2009 Sep; 6(9):2601-10. PubMed ID: 19549089
    [Abstract] [Full Text] [Related]

  • 31. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS.
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [Abstract] [Full Text] [Related]

  • 32. Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency.
    Daniell HW, Lentz R, Mazer NA.
    J Pain; 2006 Mar; 7(3):200-10. PubMed ID: 16516826
    [Abstract] [Full Text] [Related]

  • 33. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism.
    Herzog AG, Farina EL, Drislane FW, Schomer DL, Smithson SD, Fowler KM, Dworetzky BA, Bromfield EB.
    Epilepsy Behav; 2010 Feb; 17(2):264-71. PubMed ID: 20096638
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
    Wang C, Ilani N, Arver S, McLachlan RI, Soulis T, Watkinson A.
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
    [Abstract] [Full Text] [Related]

  • 35. Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.
    Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3578-83. PubMed ID: 8855804
    [Abstract] [Full Text] [Related]

  • 36. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL, Carpenter DM, Minkoff JR.
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [Abstract] [Full Text] [Related]

  • 37. Testosterone replacement therapy after primary treatment for prostate cancer.
    Agarwal PK, Oefelein MG.
    J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
    [Abstract] [Full Text] [Related]

  • 38. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M, Canty DJ, Shabsigh R.
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [Abstract] [Full Text] [Related]

  • 39. The effects of treating male hypogonadism on couples' sexual desire and function.
    Conaglen JV, Conaglen HM.
    J Sex Med; 2009 Feb; 6(2):456-63. PubMed ID: 19215616
    [Abstract] [Full Text] [Related]

  • 40. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ.
    J Androl; 1998 Feb; 19(6):761-8. PubMed ID: 9876028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.